Autres langues Infant Bacterial Therapeutics AB

Actions

IBT B

SE0008015259

Marché Fermé - Nasdaq Stockholm Autres places de cotation 15:57:57 25/04/2024			Varia. 5j.	Varia. 1 janv.
87,4 ^SEK	-0,46 %		0,00 %	-2,89 %

08/02	Infant Bacterial Therapeutics AB (publ) publie ses résultats pour l'exercice clos le 31 décembre 2023	CI
08/02	Infant Bacterial Therapeutics AB (publ) annonce ses résultats pour le quatrième trimestre clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Infant Bacterial Therapeutics : Major Milestone Achieved - Last Patient Enrolled in Infant Bacterial Therapeutics' Phase 3 Study	04/04
Major Milestone Achieved - Last Patient Enrolled in Infant Bacterial Therapeutics’ Phase 3 Study	04/04
Notice of Annual General Meeting of Infant Bacterial Therapeutics	03/04
Infant Bacterial Therapeutics AB publishes the Annual Report for 2023	25/03
Infant Bacterial Therapeutics AB (publ), Interim report January 1-December 31, 2023	08/02
Infant Bacterial Therapeutics AB Reports Earnings Results for the Full Year Ended December 31, 2023	08/02
Infant Bacterial Therapeutics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	08/02
Infant Bacterial Therapeutics AB (publ), Interim report January 1-September 30, 2023	10/11
Infant Bacterial Therapeutics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11
Infant Bacterial Therapeutics AB (publ) announces the appointment of the Nomination Committee for the Annual General Meeting 2024	24/10/23
Infant Bacterial Therapeutics AB Announces the Appointment of the Nomination Committee for the Annual General Meeting 2024	24/10/23
Infant Bacterial Therapeutics AB (publ) Interim report January 1 - June 30, 2023	25/08/23
Infant Bacterial Therapeutics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	25/08/23
New number of shares and votes in IBT	31/07/23
New number of shares and votes in IBT	31/07/23
Additional Infant Bacterial Therapeutics product receives FDA orphan drug designation	04/07/23
Sweden’s Infant Bacterial Therapeutics to Raise SEK101 Million via Rights Issue	04/07/23
IBT announces outcome of its rights issue	04/07/23
Additional Infant Bacterial Therapeutics product receives FDA orphan drug designation	03/07/23
The futility analysis for IBT’s Connection Study positive	21/06/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Infant Bacterial Therapeutics AB

Actions

IBT B

SE0008015259

Autres langues

Filtres